Loblaw Companies Limited (L)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 68.67 |
|---|---|
| 52-week range | 54.44 – 71.06 |
| Return, 1 month / 3 months | +10.9% / +8.6% |
| Return, 1 year / 3 years | +18.5% / +156.0% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 22.5% |
| Worst drawdown (1 year) | -14.5% |
| Average daily value traded | 81.55M CAD |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Loblaw Companies Limited is a Canadian retailer of food and pharmacy products, based in Brampton, Ontario. It runs supermarket chains serving everyday shoppers, from full-service grocery stores to discount food outlets, and it operates drugstores that combine pharmacy services with health and beauty products. The company also sells its own private-label food and household brands and offers financial services and apparel through its retail network, reaching customers across Canada through stores and online channels.
On this site Loblaw Companies Limited appears as a stock on the Toronto Exchange (Canada), code L, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Loblaw Companies Limited (L) trades on the Toronto Exchange in Canada. It last closed at CAD 68.67 on 23 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 87 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.5% and over the last three months it rose 8.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.7% | ||
| From 52-week high | -2.8% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.6% | ||
| 6-month return | 11.2% | ||
| 12-month return, skipping the last month | 6.9% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.5% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 81.55M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.0% |
|---|---|
| 1 month | +10.9% |
| 3 months | +8.6% |
| 6 months | +11.2% |
| 1 year | +18.5% |
| 3 years | +156.0% |
| 5 years | +218.8% |
Signals
| 50-day / 200-day average | 63.02 / 63.15 |
|---|---|
| Golden / death cross (60 days) | Death, 21 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.49 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | CAD 0.1550 |
| 15 Jun 2026 | CAD 0.1550 |
| 13 Mar 2026 | CAD 0.1410 |
| 15 Dec 2025 | CAD 0.1410 |
| 15 Sep 2025 | CAD 0.1410 |
| 13 Jun 2025 | CAD 0.5640 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.